
    
      The following dimensions will be recorded

        1. Overall physician's empathy regarding generics in glaucoma

        2. Physician's prescribing habits regarding generics in glaucoma

        3. Physician's perceptions regarding generics cost-effectiveness in glaucoma

        4. Physician's perceptions regarding adequacy of Greek regulatory authorities (generic
           market in glaucoma)

        5. Physician's perceptions regarding adequacy of European regulatory authorities (generic
           market in glaucoma)
    
  